Exact Mass: 282.129

Exact Mass Matches: 282.129

Found 500 metabolites which its exact mass value is equals to given mass value 282.129, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2-Hydroxynevirapine

2-cyclopropyl-5-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C15H14N4O2 (282.1117)

2-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 2-Hydroxynevirapine is a metabolite of Nevirapine. 2-hydroxynevirapine belongs to the family of Pyridinones. These are compounds containing a pyridine ring, which bears a ketone.

Randainol

C18H18O3 (282.1256)

NAC

4-(acetylamino)-N-(2,6-dimethylphenyl)benzamide

C17H18N2O2 (282.1368)

2,3-Diphenyl-3-(2-pyridinyl)acrylonitrile

C20H14N2 (282.1157)

GSK 4716

4-hydroxy-N-[(E)-(4-propan-2-ylphenyl)methylideneamino]benzamide

C17H18N2O2 (282.1368)

N-Acetoxy-phip

{1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-yl}amino acetate

C15H14N4O2 (282.1117)

Threonyltyrosine

(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid

C13H18N2O5 (282.1216)

Threonyltyrosine is a dipeptide composed of threonine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Tyrosyl-Threonine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-hydroxybutanoate

C13H18N2O5 (282.1216)

Tyrosyl-Threonine is a dipeptide composed of tyrosine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

12-Hydroxynevirapine

2-cyclopropyl-7-(hydroxymethyl)-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C15H14N4O2 (282.1117)

12-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 12-Hydroxynevirapine is a metabolite of Nevirapine. 12-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.

8-Hydroxynevirapine

2-cyclopropyl-13-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C15H14N4O2 (282.1117)

8-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 8-Hydroxynevirapine is a metabolite of Nevirapine. 8-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.

3-Hydroxynevirapine

2-cyclopropyl-6-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C15H14N4O2 (282.1117)

3-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 3-Hydroxynevirapine is a metabolite of Nevirapine. 3-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.

Isoeugenol phenylacetate

2-Methoxy-4-[(1Z)-prop-1-en-1-yl]phenyl 2-phenylacetic acid

C18H18O3 (282.1256)

Isoeugenol phenylacetate is a flavouring ingredient. Flavouring ingredient

Hydroxy-lacosamide

2-{[(1R)-1-{[(4-hydroxyphenyl)methyl]carbamoyl}-2-methoxyethyl]amino}acetic acid

C13H18N2O5 (282.1216)

Hydroxy-lacosamide is a metabolite of lacosamide. Lacosamide (formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. The U.S. Food and Drug Administration accepted UCBs New Drug Application for lacosamide as of November 29, 2007, beginning the approval process for the drug. (Wikipedia)

3-(2-(Benzoxazol-2-yl)ethyl)-5-ethyl-6-methylpyridin-2(1H)-one

3-[2-(1,3-benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-1,2-dihydropyridin-2-one

C17H18N2O2 (282.1368)

2H-1-Benzopyran-2-carboxylic acid, 3,4-dihydro-6-phenyl-, ethyl ester

C18H18O3 (282.1256)

4-Hydroxyequilenin

5,6-dihydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),2(7),3,5,8-pentaen-14-one

C18H18O3 (282.1256)

2,3-Dihydro-6-(3-(2-hydroxymethyl)phenyl-2-propenyl)-benzofuranol

6-{3-[2-(hydroxymethyl)phenyl]prop-2-en-1-yl}-2,3-dihydro-1-benzofuran-5-ol

C18H18O3 (282.1256)

Obovatol

5-(PROP-2-EN-1-YL)-3-[4-(PROP-2-EN-1-YL)PHENOXY]BENZENE-1,2-DIOL

C18H18O3 (282.1256)

Obovatol is a natural product found in Magnolia garrettii, Magnolia chevalieri, and other organisms with data available. Obovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb[1]. Obovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb[1].